Structural Heart Occluders

Data was positive from the Watchman Left Atrial Appendage Closure (LAAC) Device from the EWOLUTION registry
News | Atrial Fibrillation | May 30, 2017

May 30, 2017 — Data was positive for safety and efficacy rates of the Watchman Left Atrial Appendage Closure (LAAC)...

atricure atriclip, LAA occlusion, acc17

The AtriCure Atriclip surgical LAA occlusion device. It loops over the LAA on the outside of the heart and clips it off from the rest of the heart to prevent the formation of clots.

Feature | Left Atrial Appendage (LAA) Occluders | March 29, 2017

March 29, 2017 — For patients with...

Dee Dee Wang, Henry Ford Hospital, 3D printing for cardiology, 3-D

Dr. Dee Dee Wang with part of Henry Ford Hospital's collection of 3-D printed hearts used for education and to preplan structural heart procedures.

Feature | 3-D Printing | March 03, 2017

March 3, 2017 — A Henry Ford Hospital study found a 100 percent success rate in left atrial appendage (LAA)...

University of Alabama at Birmingham, Amplatzer PFO Occluder, first implementation
News | Structural Heart Occluders | February 15, 2017

February 15, 2017 — Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug...

Amplatzer PFO Occluder, St. Jude Medical, Baylor Heart and Vascular Services, Fort Worth, Texas, first patients
News | Structural Heart Occluders | February 01, 2017

February 1, 2017 — Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to...

NCDR, ACC, JACC, American College of Cardiology, national trends, heart disease treatments, trends in cardiovascular care
News | Cath Lab | January 23, 2017

January 23, 2017 — Over 93 percent of heart attack patients are receiving stents within the guideline-recommended...

watchman LAA occluder, LAAO registry
Feature | Left Atrial Appendage (LAA) Occluders | November 07, 2016

November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high...

RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders | November 02, 2016

November 2, 2016 — St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First...

St. Jude Medical, Amplatzer PFO Occluder, FDA approval, U.S. launch
Technology | Structural Heart Occluders | November 02, 2016

November 2, 2016 — St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval...

St. Jude Medical, ADO II AS trial, congenital heart disease, PDA, Amplatzer Duct Occluder II AS
News | Congenital Heart | October 19, 2016

October 19, 2016 — St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II...

St. Jude Medical, Amplatzer Amulet LAA occluder, left atrial appendage, IDE trial
News | Left Atrial Appendage (LAA) Occluders | September 02, 2016

September 2, 2016 — St. Jude Medical Inc. announced the start of the St. Jude Medical Amplatzer Amulet IDE trial of...

PFO closure, patent foramen ovale, AAN recommendation, American Academy of Neurology, stroke patients
News | Structural Heart Occluders | August 08, 2016

August 8, 2016 — Updated recommendations from the American Academy of Neurology (AAN) states that catheter-based...

Watchman, left atrial appendage closure, LAA occluder

An illustration of a Watchman transcatheter LAA occluder being implanted.

Feature | Left Atrial Appendage (LAA) Occluders | August 01, 2016 | Dave Fornell

Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in...

Videos | Structural Heart Occluders | June 16, 2016

This is an animation, supplied by Gore, demonstrated how the Cardioform Septal Occluder is implanted for the...

PFO occluder, amplatzer
Feature | Structural Heart Occluders | May 27, 2016 | Dave Fornell

May 27, 2016 — A U.S. Food and Drug Administration (FDA) panel recommended approval of a transcatheter patent...

Overlay Init